Fuisz Pharma

Fuisz Pharma Patents New Tablet, Caplet Shapes

The new shapes are designed to promote more rapid, reliable esophageal transit of oral medications.

Fuisz Pharma LLC announced today that it has received a notice of allowance from the United States Patent and Trademark Office in connection with its utility patent application entitled "Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit" (US 20120141545).  The allowed claims cover Fuisz Pharma's new tablet and caplet designs for improved transit, including the tablet that Fuisz Pharma calls the "Saturn".

No votes yet
Syndicate content